2017 annual workshop of the European network of paediatric research at the European Medicines Agency (Enpr-EMA)

• Date:
  Marți, 16 mai 2017, Toată ziua
• Locație:
  European Medicines Agency, Amsterdam, the Netherlands

The ninth annual workshop of the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) aims to bring relevant stakeholders together to discuss requirements, barriers and opportunities for high-quality clinical studies in children. Among the highlights of this year's workshop are the recent efforts to increase cooperation between the European Union and the United States to facilitate global paediatric trials and medicine developments.

Documents

Report of the 2017 annual workshop of the European network of paediatric research at the European Medicines Agency (Enpr-EMA)

Reference Number: EMA/320019/2017

Agenda - 2017 annual workshop of the European network of paediatric research at the European Medicines Agency (Enpr-EMA)

Draft Reference Number: EMA/452047/2016

Presentation - Session 1: Update on Enpr-EMA activities, achievements and challenges (Mark Turner, Irmgard Eichler)

Presentation - Session 2.1: Working Group on GCP training

Presentation - Session 2.2 - Working Group on Ethics (Pirkko Lepola)

Presentation - Session 2.3 - Working Group on Young People Advisory Groups (Pamela Dicks)

Presentation - Session 2.4: Working group on interactions networks-industry-regulators (Susan Tansey, Pirkko Lepola)

Presentation - Session 2.5: Working group antibiotics (Laura Folgori)

Presentation - Session 2.6: Examples of interactions - Accelerate (Gilles Vassal, Gustave Roussy)

Presentation - Session 2.7: Examples of interactions - PRINTO (Nicola Ruperto)

Presentation - Session 2.8: Examples of interactions - ECFS (Tim Lee)

Presentation - Session 2.9: Examples of interactions - PENTA (Carlo Giaquinto)

Presentation - Session 3.1: Updates on networks - Spanish network (Cristina Serà©n Trasorras)

Presentation - Session 3.2: Updates on networks - Nordic network (Kalle Hoppu)

Presentation - Session 3.3: Updates on networks - Irish network (Geraldine Boylan)

Presentation - Session 3.6: Updates on networks - PedCRIN (Mark Turner)

Presentation - Session 3.7: EMA framework of collaboration with academia (Isabelle Moulon)

Presentation - Session 3.8: European Reference Networks (Enrique Terol)

Presentation - Session 3.9: Potential interaction with Enpr-EMA networks

Presentation - Session 3.10: Update on the EU Portal and Database (Kevin Cunningham)

Presentation - Session 3.11: Update on EU member state harmonisation (Seà¡n Kilbride)

Presentation - Session 4.1: Collaboration European Cystic Fibrosis Society Clinical Trials Network (ECFS-CTN) with US Cystic Fibrosis Foundation –Therapeutics Development Network (CFF-TDN) (Tim Lee)

Presentation - Session 4.2: Global collaboration between regulatory agencies with paediatric research networks (Irmgard Eichler, Susan McCune)

Presentation - Session 4.3: Feedback from EC/EMA-FDA bilateral on paediatric research (Peter Karolyi)

Presentation - Session 4.5: Interaction and cooperation between the EU and US on global paediatric research: ICAN’s experience (Joana Claverol)

Presentation - Session 4.6: Action points and conclusions (Mark Turner)